Strides Pharma Science Ltd - STAR: Profit & Loss Statement

Profit & Loss Statement of Strides Pharma Science Ltd

Switch to

Switch to

Y/e 31 Mar ( In .Cr)	Mar-2021	Mar-2020	Mar-2018	Mar-2017
Revenue	3,316	2,752	2,839	2,755
yoy growth (%)	20.50	(3.10)	3.05	(3.70)
Raw materials	(1,333)	(1,122)	(1,379)	(1,281)
As % of sales	40.20	40.80	48.60	46.50
Employee costs	(550)	(443)	(434)	(419)
As % of sales	16.60	16.10	15.30	15.20
Other costs	(798)	(671)	(630)	(528)
As % of sales	24.10	24.40	22.20	19.20
Operating profit	635	516	397	527
OPM	19.10	18.70	14	19.10
Depreciation	(206)	(174)	(154)	(126)
Interest expense	(150)	(156)	(196)	(183)
Other income	51.40	53.10	94.10	161
Profit before tax	330	240	140	379
Taxes	(32)	(11)	(9.70)	(63)
Tax rate	(9.60)	(4.70)	(6.90)	(17)
Minorities and other	24.70	(7)	590	120
Adj. profit	323	221	721	436
Exceptional items	43.40	(78)	(44)	(36)
Net profit	268	36.40	660	400
yoy growth (%)	638	(94)	65.20	268
NPM	8.10	1.32	23.30	14.50